Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer's Disease Pathology

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zou, Fanggeng ^a   Belbin, Olivia ^a,b,d   Carrasquillo, Minerva M ^a   Culley, Oliver J ^a   Hunter, Talisha A ^a   Ma, Li ^a   Bisceglio, Gina D ^a   Allen, Mariet ^a   Dickson, Dennis W ^a   Graff Radford, Neill R ^a   Petersen, Ronald C ^c   Morgan, Kevin ^b   Younkin, Steven G ^a   Harold, Denise ^e   Sims, Rebecca ^e   Gerrish, Amy ^e   Chapman, Jade ^e   Moskvina, Valentina ^e   Abraham, Richard ^e   Hollingworth, Paul ^e   Hamshere, Marian ^e   Singh Pahwa, Jaspreet ^e   Dowzell, Kimberley ^e   Williams, Amy ^e   Jones, Nicola ^e   Thomas, Charlene ^e   Stretton, Alexandra ^e   Morgan, Angharad ^e   Williams, Kate ^e   Lovestone, Simon ^f   Powell, John ^f   Proitsi, Petroula ^f   Lupton, Michelle K ^f   Brayne, Carol ^g   Rubinsztein, David C ^h   Gill, Michael ⁱ   Lawlor, Brian ⁱ   Lynch, Aoibhinn ⁱ   Brown, Kristelle ^b   Passmore, Peter ^j   Craig, David ^j   McGuinness, Bernadette ^j   Johnston, Janet A ^j   Todd, Stephen ^j   Holmes, Clive ^k   Mann, David ^l   David Smith, A ^m   Love, Seth ⁿ   Kehoe, Patrick G ⁿ   Hardy, John ^o   Guerreiro, Rita ^p,q   Singleton, Andrew ^p   Mead, Simon ^q   Fox, Nick ^q   Rossor, Martin ^q   Collinge, John ^q   Maier, Wolfgang ^r   Jessen, Frank ^r   Heun, Reiner ^r   Schürmann, Britta ^r   Ramirez, Alfredo ^r   Herold, Christine ^ae   Lacour, André ^ae   Drichel, Dmitriy ^ae   van den Bussche, Hendrik ^s   Heuser, Isabella ^t   Kornhuber, Johannes ^u   Wiltfang, Jens ^v   Dichgans, Martin ^w   Frölich, Lutz ^x   Hampel, Harald ^y   Hüll, Michael ^z   Rujescu, Dan ^w   Goate, Alison ^aa   Kauwe, John S K ^ab   Cruchaga, Carlos ^aa   Nowotny, Petra ^aa   Morris, John C ^aa   Mayo, Kevin ^aa   Livingston, Gill ^ac   Bass, Nicholas J ^ac   Gurling, Hugh ^ac   McQuillin, Andrew ^ac   Gwilliam, Rhian ^ad   Deloukas, Panagiotis ^ad   Nöthen, Markus M ^r   Holmans, Peter ^e   O’Donovan, Michael ^e   Owen, Michael J ^e   Williams, Julie ^e   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MAYO CLINIC   (United States)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ ST JAMES S HOSPITAL   (Ireland)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSITY OF BRISTOL   (United Kingdom)

^o UNIVERSITY COLLEGE LONDON   (United Kingdom)

^p NATIONAL INSTITUTE ON AGING   (United States)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF BONN   (Germany)

^s UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^u UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^v UNIVERSITY OF DUISBURG ESSEN   (Germany)

^w LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^x MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^y GOETHE UNIVERSITY   (Germany)

^z UNIVERSITY OF FREIBURG   (Germany)

^aa WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ab BRIGHAM YOUNG UNIVERSITY   (United States)

^ac UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ad WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^ae GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GRB ASSOCIATED BINDING PROTEIN 2 GENE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; TEMPORAL CORTEX; UPREGULATION;

EID: 84878423504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064802     Document Type: Article

References (34)

1. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
2. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
3. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840.
4. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67: 961-964.
5. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2011) Replication of BIN1 Association with Alzheimer's Disease and Evaluation of Genetic Interactions. J Alzheimers Dis.
6. Hu X, Pickering E, Liu YC, Hall S, Fournier H, et al. (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One 6: e16616.
7. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441.
8. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435.
9. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, et al. (2010) Identification of Novel Loci for Alzheimer Disease and Replication of CLU, PICALM, and BIN1 in Caribbean Hispanic Individuals. Arch Neurol.
10. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Arch Neurol.
11. Bertram L, McQueen M, Mullin K, Blacker D, Tanzi R (2006) The AlzGene Database. Available at: http://www.alzgene.org (Accessed 2013 April 30).
12. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, et al. (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54: 713-720.
13. Bertram L, Tanzi RE, (2009) Genome-wide association studies in Alzheimer's disease. Hum Mol Genet 18: R137-145.
14. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, et al. (2009) Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry.
15. Ikram MA, Liu F, Oostra BA, Hofman A, van Duijn CM, et al. (2009) The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis. Biol Psychiatry 65: 995-999.
16. Nacmias B, Tedde A, Bagnoli S, Cellini E, Guarnieri BM, et al. (2009) Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease. J Alzheimers Dis 16: 513-515.
17. Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, et al. (2009) Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Hum Mutat 30: E338-344.
18. Chapuis J, Hannequin D, Pasquier F, Bentham P, Brice A, et al. (2008) Association study of the GAB2 gene with the risk of developing Alzheimer's disease. Neurobiol Dis 30: 103-106.
19. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, et al. (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65: 45-53.
20. Ramirez-Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, et al. (2009) GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers. J Nutr Health Aging 13: 214-219.
21. Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, et al. (2009) GAB2 is not associated with late-onset Alzheimer's disease in Japanese. Eur J Hum Genet 17: 682-686.
22. Lin K, Tang M, Han H, Guo Y, Lin Y, et al. (2010) GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han. Neurol Sci 31: 277-281.
23. Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, et al. (2011) Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum Genet 129: 273-282.
24. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202-1207.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
26. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
27. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I, (2004) VISTA: computational tools for comparative genomics. Nucleic Acids Res 32: W273-279.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
29. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
30. Pratt JC, Igras VE, Maeda H, Baksh S, Gelfand EW, et al. (2000) Cutting edge: gab2 mediates an inhibitory phosphatidylinositol 3'-kinase pathway in T cell antigen receptor signaling. J Immunol 165: 4158-4163.
31. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, et al. (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J 23: 2586-2596.
32. Carrasquillo MM, Belbin O, Zou F, Allen M, Ertekin-Taner N, et al. (2010) Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. PLoS One 5: e8764.
33. Zou F, Carrasquillo MM, Pankratz VS, Belbin O, Morgan K, et al. (2010) Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology 74: 480-486.
34. Schjeide BM, Hooli B, Parkinson M, Hogan MF, DiVito J, et al. (2009) GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. Arch Neurol 66: 250-254.